FDA staff affirms efficacy of Vertex's hepatitis C drug telaprevir

04/26/2011 | Boston Globe (tiered subscription model), The · Bloomberg

FDA reviewers backed pivotal trial data indicating that adding Vertex Pharmaceuticals' telaprevir to standard combination therapy is effective in curing hepatitis C and cutting down duration of treatment. An advisory panel will decide Thursday whether to recommend the drug's approval.

View Full Article in:

Boston Globe (tiered subscription model), The · Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN